Delivery Order SPE2DB22D3501-SPE2DB25FXH93
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,016.67 and is structured as a firm fixed-price delivery order with an ultimate completion date of September 16, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitive delivery order, with a ceiling value of $1,066.35 and firm fixed pricing, represents a continuation of the contractor's pharmaceutical supply services to federal military and healthcare systems. The order will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with...
- The Defense Logistics Agency awarded a delivery order valued at $1,652.48 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $3,663.93 firm fixed price delivery order to AmerisourceBergen Drug Corp for cefpodoxime 200 mg tablets (20-count) with a completion date of September 2, 2025. This contract is classified as a non-set-aside award, meaning it was competitively awarded without restrictions on eligible bidders. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Cefpodoxime 200 mg tablets in quantities of 20 for a ceiling value of $1,949.17. This contract represents a non-set-aside, competitively awarded delivery order utilizing firm fixed pricing and is scheduled for completion by August 19, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $8,233.44 delivery order to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets (20-count packages) under a firm fixed-price contract. The order, issued on September 13, 2025, with an ultimate completion date of September 15, 2025, represents a non-set-aside competitive award to support federal medical procurement needs. Performance will be executed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $1,271.27 to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 units. This competitively awarded, non-set-aside contract carries a firm fixed price structure with an ultimate completion date of April 22, 2025, and performance will be executed from the contractor's facility in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's broader relationship...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Cefpodoxime 200 mg tablets in quantities of 20 tablets, with a ceiling value of $2,615.55. The contract, awarded on August 13, 2025, is structured as a firm fixed price delivery order with an ultimate completion date of August 14, 2025. This award was not set-aside and represents a competitively awarded transaction. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,705.38 firm fixed-price contract is for the delivery of 4,567,914,247 units of the antibiotic cefpodoxime 200 mg tablets. The contract has an ultimate completion date of April 16, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,567,300,894 units of the prescription drug Cefpodoxime 100 mg tablets. The $5,808.14 firm fixed-price contract has a completion date of February 19, 2025. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB25FXH93Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Cefpodoxime 200 mg tablets in quantities of 20 on September 15, 2025, with a ceiling value of $4,047.00 and an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. As a prime contractor under the DLA's comprehensive pharmaceutical supply vehicle, the company fulfills a broad portfolio of pharmaceutical products and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems worldwide. This specific delivery order represents a routine pharmaceutical procurement within the broader SPE2DX contract framework, demonstrating the company's continued role as a key supplier in the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.0k | 9/15/25 |